OTC Pharmaceuticals - Guinea

  • Guinea
  • Revenue in the OTC Pharmaceuticals market amounts to US$56.96m in 2024. The market is expected to grow annually by 8.13% (CAGR 2024-2029).
  • The market's largest segment is the segment Skin Treatment with a market volume of US$14.13m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$3.92 are generated in 2024.
  • In the OTC Pharmaceuticals market, 3.4% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Guinea is experiencing steady growth due to increasing customer preferences for self-medication and the availability of a wide range of over-the-counter products.

Customer preferences:
Customers in Guinea are increasingly opting for self-medication, driven by factors such as convenience, accessibility, and cost-effectiveness. With the growing awareness of common health conditions and the availability of information online, consumers are more inclined to take charge of their own health and seek out OTC products for relief from minor ailments. This shift in consumer behavior is contributing to the growth of the OTC Pharmaceuticals market in Guinea.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Guinea is the rising demand for analgesics and antipyretics. These products, which include pain relievers and fever reducers, are widely used for common ailments such as headaches, muscle aches, and fevers. The increasing prevalence of these health issues, coupled with the ease of access to OTC analgesics and antipyretics, is driving the growth of this segment in the market. Another trend in the market is the growing demand for gastrointestinal medications. Digestive disorders such as indigestion, heartburn, and diarrhea are common among the population in Guinea. As a result, there is a high demand for OTC gastrointestinal medications that provide relief from these symptoms. The availability of a variety of OTC products targeting different gastrointestinal issues is fueling the growth of this segment in the market.

Local special circumstances:
One of the local special circumstances in Guinea is the limited access to healthcare facilities, especially in rural areas. This lack of access to professional medical care has led to an increased reliance on self-medication and OTC products. Consumers in these areas often turn to OTC Pharmaceuticals as a first line of defense for common health issues, further driving the growth of the market.

Underlying macroeconomic factors:
The OTC Pharmaceuticals market in Guinea is also influenced by underlying macroeconomic factors. The country has been experiencing steady economic growth, which has led to an increase in disposable income among the population. As a result, consumers have more purchasing power to spend on healthcare products, including OTC Pharmaceuticals. Additionally, the government has implemented policies to improve healthcare infrastructure and promote the availability of affordable OTC products, further supporting the growth of the market. In conclusion, the OTC Pharmaceuticals market in Guinea is growing due to increasing customer preferences for self-medication, the rising demand for analgesics and antipyretics, and the growing demand for gastrointestinal medications. The limited access to healthcare facilities and the underlying macroeconomic factors of the country also contribute to the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)